AR and prostate cancer: In prostate cancer, O-GlcNAcylation occurs on the androgen receptor (AR) protein at the Thr-80 residue next to the Ser-81 phosphorylation site, which leads to stabilization, nuclear translocation, and transactivation of AR (75).